SCHEMBL15537785

SCHEMBL15537785

O=C(O)c1cc(C2CC2)c(OCC2CCC3C(C2)C3(F)F)cc1F

nearest known ligand 0.72

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 20/20 0.72
▸ SCN5A Q14524 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30261423 0.86 SCN9A (0.61) SCN9ASCN5A
SCHEMBL16448738 0.86 SCN9A (0.68) SCN9ASCN5A
SCHEMBL15537384 0.86 SCN9A (0.63) SCN9ASCN5A
SCHEMBL16448559 0.84 SCN9A (1.00) SCN9ASCN5A
SCHEMBL16448560 0.83 SCN9A (1.00) SCN9ASCN5A
SCHEMBL15536025 0.83 SCN9A (0.71) SCN9ASCN5A
SCHEMBL16449076 0.83 SCN9A (0.71) SCN9ASCN5A
SCHEMBL15535642 0.83 SCN9A (0.70) SCN9ASCN5A
SCHEMBL15536474 0.82 SCN9A (0.69) SCN9ASCN5A
SCHEMBL15536309 0.82 SCN9A (0.57) SCN9ASCN5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2855428-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN Genentech, Inc. (US) 2015-04-08 — — EP disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 — — US disclosed
US-8952169-B2 N-substituted benzamides and methods of use thereof XENON PHARMACEUTICALS INC. (CA) 2015-02-10 — — US disclosed
WO-2013177224-A1 N-SUBSTITUTED BENZAMIDES AND THEIR USE IN THE TREATMENT OF PAIN GENENTECH, INC. (US) 2013-11-28 — — WO disclosed
Send feedback